Langerhans cells and viral immunity

European Journal of Immunology

Volumn 38, Issue 9, 2008, Pages 2377-2385

  Cunningham, Anthony L ^a   Carbone, Francis ^b   Geijtenbeek, Teunis B H ^c  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Dendritic cells; Herpesviruses; HIV; Infectious diseases; Langerhans cells

Indexed keywords

ADAPTIVE IMMUNITY; ANTIGEN PRESENTING CELL; DENDRITIC CELL; EPIDERMIS; HERPES SIMPLEX; HERPES ZOSTER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INNATE IMMUNITY; LANGERHANS CELL; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SHORT SURVEY; SQUAMOUS EPITHELIUM; VARICELLA ZOSTER VIRUS; VIRUS IMMUNITY; VIRUS TRANSMISSION; ACTIVE IMMUNIZATION; ANIMAL; DISEASE TRANSMISSION; HERPES SIMPLEX VIRUS; HERPES VIRUS INFECTION; IMMUNOLOGY; METABOLISM; MOUSE; PHYSIOLOGY; REVIEW; VIROLOGY;

ANIMALS; DENDRITIC CELLS; HERPES SIMPLEX; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 3, HUMAN; HIV INFECTIONS; HIV-1; HUMANS; IMMUNITY, ACTIVE; IMMUNITY, NATURAL; LANGERHANS CELLS; MICE; SIMPLEXVIRUS;

EID: 55249106994     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.200838521     Document Type: Short Survey

References (88)

1. Stingl, G., Tamaki, K. and Katz, S. I., Origin and function of epidermal Langerhans cells. Immunol. Rev. 1980. 53: 149-174.
2. Kaplan, D. H., Kissenpfenning, A. and Clausen, B. E., Insights into Langerhans cell function from Langerhans cell ablation models. Eur. J. Immunol. 2008. 38: DOI 10.1002/eji.200838397.
3. He, Y., Zhang, J., Donahue, C. and Falo, Jr. L. D., Skin-derived dendritic cells induce potent CD8(+) T cell immunity in recombinant lentivector-mediated genetic immunization. Immunity 2006. 24: 643-656.
4. Mayerova, D., Parke, E. A., Bursch, L. S., Odumade, O. A. and Hogquist, K. A., Langerhans cells activate naive self-antigen-specific CD8 T cells in the steady state. Immunity 2004. 21: 391-400.
5. Cumberbatch, M., Singh, M., Dearman, R. J., Young, H. S., Kimber, I. and Griffiths, C. E., Impaired Langerhans cell migration in psoriasis. J. Exp. Med. 2006. 203: 953-960.
6. Jiang, A., Bloom, O., Ono, S., Cui, W., Unternaehrer, J., Jiang, S., Whitney, J. A. et al., Disruption of E-cadherin-mediated adhesion induces a functionally distinct pathway of dendritic cell maturation. Immunity 2007. 27: 610-624.
7. Waithman, J., Allan, R. S., Kosaka, H., Azukizawa, H., Shortman, K., Lutz, M. B., Heath, W. R. et al., Skin-derived dendritic cells can mediate deletional tolerance of class I-restricted self-reactive T cells. J. Immunol. 2007. 179: 4535-4541.
8. van der Aar, A. M., Sylva-Steenland, R. M., Bos, J. D., Kapsenberg, M. L., de Jong, E. C. and Teunissen, M. B., Loss of, TLR2, TLR4, and TLR5 on Langerhans cells abolishes bacterial recognition. J. Immunol. 2007. 178: 1986-1990.
9. Flacher, V., Bouschbacher, M., Verronese, E., Massacrier, C., Sisirak, V., Berthier-Vergnes, O., de Saint-Vis, B. et al., Human Langerhans cells express a specific TLR profile and differentially respond to viruses and Gram-positive bacteria. J. Immunol. 2006. 177: 7959-7967.
10. Filippi, C., Hugues, S., Cazareth, J., Julia, V., Glaichenhaus, N. and Ugolini, S., CD4+ T cell polarization in mice is modulated by strain-specific major histocompatibility complex-independent differences within dendritic cells. J. Exp. Med. 2003. 198: 201-209.
11. + T cell activation in vivo: With help from interleukin 1. J. Exp. Med. 2003. 198: 185-190.
12. Zhao, X., Deak, E., Soderberg, K., Linehan, M., Spezzano, D., Zhu, J., Knipe, D. M. and Iwasaki, A., Vaginal submucosal dendritic cells, but not Langerhans cells, induce protective Th1 responses to herpes simplex virus-2. J. Exp. Med. 2003. 197: 153-162.
13. Bursch, L. S., Wang, L., Igyarto, B., Kissenpfennig, A., Malissen, B., Kaplan, D. H. and Hogquist, K. A., Identification of a novel population of Langerin+ dendritic cells. J. Exp. Med. 2007. 204: 3147-3156.
14. Ginhoux, F., Collin, M. P., Bogunovic, M., Abel, M., Leboeuf, M., Helft, J., Ochando, J. et al., Blood-derived dermal langerin+ dendritic cells survey the skin in the steady state. J. Exp. Med. 2007. 204: 3133-3146.
15. Poulin, L. F., Henri, S., de Bovis, B., Devilard, E., Kissenpfennig, A. and Malissen, B., The dermis contains langerin+ dendritic cells that develop and function independently of epidermal Langerhans cells. J. Exp. Med. 2007. 204: 3119-3131.
16. Zhang, Z., Schuler, T., Zupancic, M., Wietgrefe, S., Staskus, K. A., Reimann, K. A., Reinhart, T. A. et al., Sexual transmission and propagation of SIV and HIV in resting and activated CD4+ T cells. Science 1999. 286: 1353-1357.
17. Gupta, P., Collins, K. B., Ratner, D., Watkins, S., Naus, G. J., Landers, D. V. and Patterson, B. K., Memory CD4(+) T cells are the earliest detectable human immunodeficiency virus type 1 (HIV-1)-infected cells in the female genital mucosal tissue during HIV-1 transmission in an organ culture system. J. Virol. 2002. 76: 9868-9876.
18. Shattock, R. J. and Moore, J. P., Inhibiting sexual transmission of HIV-1 infection. Nat. Rev. Microbiol. 2003. 1: 25-34.
19. Steinbrook, R., One step forward, two steps back - will there ever be an AIDS vaccine? N. Engl. J. Med. 2007. 357: 2653-2655.
20. Moszynski, P., Halt to microbicide trial sets back AIDS research. BMJ 2007. 334: 276.
21. Hladik, F., Sakchalathorn, P., Ballweber, L., Lentz, G., Fialkow, M., Eschenbach, D. and McElrath, M. J., Initial events in establishing vaginal entry and infection by human immunodeficiency virus type-1. Immunity 2007. 26: 257-270.
22. Miller, C. J. and Hu, J., T cell-tropic simian immunodeficiency virus (SIV) and simian-human immunodeficiency viruses are readily transmitted by vaginal inoculation of rhesus macaques, and Langerhans' cells of the female genital tract are infected with SIV. J. Infect. Dis. 1999. 179 (Suppl 3): S413-S417.
23. Miller, C. J., Vogel, P., Alexander, N. J., Dandekar, S., Hendrickx, A. G. and Marx, P. A., Pathology and localization of simian immunodeficiency virus in the reproductive tract of chronically infected male rhesus macaques. Lab. Invest. 1994. 70: 255-262.
24. Kawamura, T., Gulden, F. O., Sugaya, M., McNamara, D. T., Borris, D. L., Lederman, M. M., Orenstein, J. M. et al., R5 HIV productively infects Langerhans cells, and infection levels are regulated by compound CCR5 polymorphisms. Proc. Natl. Acad. Sci. USA 2003. 100: 8401-8406.
25. de Witte, L., Nabatov, A., Pion, M., Fluitsma, D., de Jong, M. A., de Gruijl, T., Piguet, V. et al., Langerin is a natural barrier to HIV-1 transmission by Langerhans cells. Nat. Med. 2007. 13: 367-371.
26. Geijtenbeek, T. B., Kwon, D. S., Torensma, R., van Vliet, S. J., van Duijnhoven, G. C., Middel, J., Cornelissen, I. L. et al., DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 2000. 100: 587-597.
27. de Witte, L., Bobardt, M., Chatterji, U., Degeest, G., David, G., Geijtenbeek, T. B. and Gallay, P., Syndecan-3 is a dendritic cell-specific attachment receptor for HIV-1. Proc. Natl. Acad. Sci. USA 2007. 104: 19464-19469.
28. Turville, S. G., Santos, J. J., Frank, I., Cameron, P. U., Wilkinson, J., Miranda-Saksena, M., Dable, J. et al., Immunodeficiency virus uptake, turnover, and 2-phase transfer in human dendritic cells. Blood 2004. 103: 2170-2179.
29. McDonald, D., Wu, L., Bohks, S. M., KewalRamani, V. N., Unutmaz, D. and Hope, T. J., Recruitment of HIV and its receptors to dendritic cell-T cell junctions. Science 2003. 300: 1295-1297.
30. Frank, I., Stossel, H., Gettie, A., Turville, S. G., Bess, Jr J. W., Lifson, J. D., Sivin, I. et al., A fusion inhibitor prevents spread of immunodeficiency viruses, but not activation of virus-specific T cells, by dendritic cells. J. Virol. 2008. 82: 5329-5339.
31. Ganesh, L., Leung, K., Lore, K., Levin, R., Panet, A., Schwartz, O., Koup, R. A. and Nabel, G. J., Infection of specific dendritic cells by CCR5-tropic human immunodeficiency virus type 1 promotes cell-mediated transmission of virus resistant to broadly neutralizing antibodies. J. Virol. 2004. 78: 11980-11987.
32. Groot, F., Kuijpers, T. W., Berkhout, B. and de Jong, E. C., Dendritic cell-mediated HIV-1 transmission to T cells of LAD-1 patients is impaired due to the defect in LFA-1. Retrovirology 2006. 3: 75.
33. Turville, S. G., Aravantinou, M., Stossel, H., Romani, N. and Robbiani, M., Resolution of de novo HIV production and trafficking in immature dendritic cells. Nat. Methods 2008. 5: 75-85.
34. Kawamura, T., Koyanagi, Y., Nakamura, Y., Ogawa, Y., Yamashita, A., Iwamoto, T., Ito, M. et al., Significant virus replication in Langerhans cells following application of HIV to abraded skin: Relevance to occupational transmission of HIV. J. Immunol. 2008. 180: 3297-3304.
35. Cunningham, A. L., Harman, A. N. and Donaghy, H., DC-SIGN 'AIDS' HIV immune evasion and infection. Nat. Immunol. 2007. 8: 556-558.
36. Reece, J. C., Handley, A. J., Anstee, E. J., Morrison, W. A., Crowe, S. M. and Cameron, P. U., HIV-1 selection by epidermal dendritic cells during transmission across human skin. J. Exp. Med. 1998. 187: 1623-1631.
37. Pope, M., Betjes, M. G., Romani, N., Hirmand, H., Cameron, P. U., Hoffman, L., Gezelter, S. et al., Conjugates of dendritic cells and memory T lymphocytes from skin facilitate productive infection with HIV-1. Cell 1994. 78: 389-398.
38. Fahrbach, K. M., Barry, S. M., Ayehunie, S., Lamore, S., Klausner, M. and Hope, T. J., Activated CD34-derived Langerhans cells mediate transinfection with human immunodeficiency virus. J. Virol. 2007. 81: 6858-6868.
39. + T cells. J. Exp. Med. 2005. 201: 2023-2033.
40. + T cells. Nature. 2002. 417: 95-98.
41. Smed-Sorensen, A., Lore, K., Vasudevan, J., Louder, M. K., Andersson, J., Mascola, J. R., Spetz, A.-L. and Koup, R. A., Differential susceptibility to human immunodeficiency virus type 1 infection of myeloid and plasmacytoid dendritic cells. J. Virol. 2005. 79: 8861-8869.
42. Wilflingseder, D., Mullauer, B., Schramek, H., Banki, Z., Pruenster, M., Dierich, M. P. and Stoiber, H., HIV-1-induced migration of monocyte-derived dendritic cells is associated with differential activation of MAPK pathways. J. Immunol. 2004. 173: 7497-7505.
43. Cunningham, A. L., Turner, R. R., Miller, A. C., Para, M. F. and Merigan, T. C., Evolution of recurrent herpes simplex lesions. An immunohistologic study. J. Clin. Invest. 1985. 75: 226-233.
44. Koelle, D. M. and Corey, L., Herpes simplex: Insights on pathogenesis and possible vaccines. Annu. Rev. Med. 2008. 59: 381-395.
45. Khanna, K. M., Lepisto, A. J., Decman, V. and Hendricks, R. L., Immune control of herpes simplex virus during latency. Curr. Opin. Immunol. 2004. 16: 463-469.
46. Verjans, G. M., Hintzen, R. Q., van Dun, J. M., Poot, A., Milikan, J. C., Laman, J. D., Langerak, A. W. et al., Selective retention of herpes simplex virus-specific T cells in latently infected human trigeminal ganglia. Proc. Natl. Acad. Sci. USA 2007. 104: 3496-3501.
47. Koelle, D. M., Frank, J. M., Johnson, M. L. and Kwok, W. W., Recognition of herpes simplex virus type 2 tegument proteins by CD4 T cells infiltrating human genital herpes lesions. J. Virol. 1998. 72: 7476-7483.
48. Simmons, A. and Tscharke, D. C., Anti-CD8 impairs clearance of herpes simplex virus from the nervous system: Implications for the fate of virally infected neurons. J. Exp. Med. 1992. 175: 1337-1344.
49. Mikloska, Z., Danis, V. A., Adams, S., Lloyd, A. R., Adrian, D. L. and Cunningham, A. L., In vivo production of cytokines and beta (C-C) chemokines in human recurrent herpes simplex lesions - do herpes simplex virus-infected keratinocytes contribute to their production? J. Infect. Dis. 1998. 177: 827-838.
50. + T lymphocytes. Cell 1994. 77: 525-535.
51. York, I. A. and Johnson, D. C., Direct contact with herpes simplex virus-infected cells results in inhibition of lymphokine-activated killer cells because of cell-to-cell spread of virus. J. Infect-Dis. 1993. 168: 1127-1132.
52. Mikloska, Z., Kesson, A. M., Penfold, M. E. and Cunningham, A. L., Herpes simplex virus protein targets for CD4 and CDB lymphocyte cytotoxicity in cultured epidermal keratinocytes treated with interferon-gamma. J. Infect. Dis. 1996. 173: 7-17.
53. Sprecher, E. and Becker, Y., Skin Langerhans cells play an essential role in the defense against HSV-1 infection. Arch. Virol. 1986. 91: 341-349.
54. Sprecher, E. and Becker, Y., Langerhans cell density and activity in mouse skin and lymph nodes affect herpes simplex type 1 (HSV-1) pathogenicity. Arch. Virol. 1989. 107: 191-205.
55. Hengel, H., Lindner, M., Wagner, H. and Heeg, K., Frequency of herpes simplex virus-specific murine cytotoxic T lymphocyte precursors in mitogen- and antigen-driven primary in vitro T cell responses. J. Immunol. 1987. 139: 4196-4202.
56. Sprecher, E. and Becker, Y., Detection of IL-1 beta, TNF-alpha, and IL-6 gene transcription by the polymerase chain reaction in keratinocytes, Langerhans cells and peritoneal exudate cells during infection with herpes simplex virus-1. Arch. Virol. 1992. 126: 253-269.
57. Allan, R. S., Smith, C. M., Belz, G. T., van Lint, A. L., Wakim, L. M., Heath, W. R. and Carbone, F. R., Epidermal viral immunity induced by CD8alpha + dendritic cells but not by Langerhans cells. Science 2003. 301: 1925-1928.
58. De Jong, M. A., deWitte, L., Bolmstedt, A., van Kooyk, Y. and Geijtenbeek, T. B., Dendritic cells mediate herpes simplex virus infection and transmission through the C-type lectin DC-SIGN. J. Gen. Virol. 2008. In press.
59. Mikloska, Z., Bosnjak, L. and Cunningham, A. L., Immature monocyte-derived dendritic cells are productively infected with herpes simplex virus type 1. J. Virol. 2001. 75: 5958-5964.
60. Kruse, M., Rosorius, O., Kratzer, F., Stelz, G., Kuhnt, C., Schuler, G., Hauber, J. and Steinkasserer, A., Mature dendritic cells infected with herpes simplex virus type 1 exhibit inhibited T-cell stimulatory capacity. J. Virol. 2000. 74: 7127-7136.
61. Jones, C. A., Fernandez, M., Herc, K., Bosnjak, L., Miranda-Saksena, M., Boadle, R. A. and Cunningham, A., Herpes simplex virus type 2 induces rapid cell death and functional impairment of murine dendritic cells in vitro. J. Virol. 2003. 77: 11139-11149.
62. Salio,M., Cella,M., Suter,M. and Lanzavecchia, A., Inhibition of dendritic cell maturation by herpes simplex virus. Eur. J. Immunol. 1999. 29: 3245-3253.
63. Snijders, A., Kalinski, P., Hilkens, C. M. and Kapsenberg, M. L., High-level IL-12 production by human dendritic cells requires two signals. Int. Immunol. 1998. 10: 1593-1598.
64. Cella, M., Facchetti, F., Lanzavecchia, A. and Colonna, M., Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent TH1 polarization. Nat. Immunol. 2000. 1: 305-310.
65. Cunningham, A. L. and Mikloska, Z., The Holy Grail: Immune control of human herpes simplex virus infection and disease. Herpes 2001. 8(Suppl 1): 6A-10A.
66. Stanberry, L. R., Spruance, S. L., Cunningham, A. L., Bernstein, D. I., Mindel, A., Sacks, S., Tyring, S. et al., Glycoprotein-D-adjuvant vaccine to prevent genital herpes. N. Engl. J. Med. 2002. 347: 1652-1661.
67. Bosnjak, L., Miranda-Saksena, M., Koelle, D. M., Boadle, R. A., Jones, C. A. and Cunningham, A. L., Herpes simplex virus infection of human dendritic cells induces apoptosis and allows cross-presentation via uninfected dendritic cells. J. Immunol. 2005. 174: 2220-2227.
68. Aubert, M., O'Toole, J. and Blaho, J. A., Induction and prevention of apoptosis in human HEp-2 cells by herpes simplex virus type 1. J. Virol. 1999. 73: 10359-10370.
69. Aubert, M., Rice, S. A. and Blaho, J. A., Accumulation of herpes simplex virus type 1 early and leaky-late proteins correlates with apoptosis prevention in infected human HEp-2 cells. J. Virol. 2001. 75: 1013-1030.
70. Galvan, V. and Roizman, B., Herpes simplex virus 1 induces and blocks apoptosis at multiple steps during infection and protects cells from exogenous inducers in a cell-type-dependent manner. Proc. Natl. Acad. Sci. USA 1998. 95: 3931-3936.
71. Jerome, K. R., Fox, R., Chen, Z., Sears, A. E., Lee, H. and Corey, L., Herpes simplex virus inhibits apoptosis through the action of two genes, Us5 and Us3. J. Virol. 1999. 73: 8950-8957.
72. Zhou, G. and Roizman, B., The domains of glycoprotein D required to block apoptosis depend on whether glycoprotein D is present in the virions carrying herpes simplex virus 1 genome lacking the gene encoding the glycoprotein. J. Virol. 2001. 75: 6166-6172.
73. Perkins, D., Pereira, E. F. and Aurelian, L., The herpes simplex virus type 2 R1 protein kinase (ICP10 PK) functions as a dominant regulator of apoptosis in hippocampal neurons involving activation of the ERK survival pathway and upregulation of the antiapoptotic protein Bag-1. J. Virol. 2003. 77: 1292-1305.
74. Langelier, Y., Bergeron, S., Chabaud, S., Lippens, J., Guilbault, C., Sasseville, A. M., Denis, S. et al., The R1 subunit of herpes simplex virus ribonucleotide reductase protects cells against apoptosis at, or upstream of, caspase-8 activation. J. Gen. Virol. 2002. 83: 2779-2789.
75. Mastino, A., Sciortino, M. T., Medici, M. A., Perri, D., Ammendolia, M. G., Grelli, S., Amici, C. et al., Herpes simplex virus 2 causes apoptotic infection in monocytoid cells. Cell Death Differ. 1997. 4: 629-638.
76. Raftery, M. J., Behrens, C. K., Muller, A., Krammer, P. H., Walczak, H. and Schonrich, G., Herpes simplex virus type 1 infection of activated cytotoxic T cells: Induction of fratricide as a mechanism of viral immune evasion. J. Exp. Med. 1999. 190: 1103-1114.
77. Ito, M., Koide, W., Watanabe, M., Kamiya, H., Sakurai, M., Apoptosis of cord blood T lymphocytes by herpes simplex virus type 1. J. Gen. Virol. 1997. 78: 1971-1975.
78. + T cells: A new role for plasmacytoid dendritic cells in adaptive immunity. Blood 2003. 101: 3520-3526.
79. Larsson, M., Fonteneau, J. F., Somersan, S., Sanders, C., Bickham, K., Thomas, E. K., Mahnke, K., Bhardwaj, N., Efficiency of cross presentation of vaccinia virus-derived antigens by human dendritic cells. Eur. J. Immunol. 2001. 31: 3432-3442.
80. Motta, I., Andre, F., Lim, A., Tartaglia, J., Cox, W. I., Zitvogel, L., Angevin, E., Kourilsky, P., Cross-presentation by dendritic cells of tumor antigen expressed in apoptotic recombinant canarypox virus-infected dendritic cells. J. Immunol. 2001. 167: 1795-1802.
81. Larsson, M., Fonteneau, J. F., Lirvall, M., Haslett, P., Lifson, J. D. and Bhardwaj, N., Activation of HIV-1 specific CD4 and CD8 T cells by human dendritic cells: Roles for cross-presentation and non-infectious HIV-1 virus. AIDS 2002. 16: 1319-1329.
82. Maranon, C., Desoutter, J. F., Hoeffel, G., Cohen, W., Hanau, D. and Hosmalin, A., Dendritic cells cross-present HIV antigens from live as well as apoptotic infected CD4+ T lymphocytes. Proc. Natl. Acad. Sci. USA 2004. 101: 6092-6097.
83. Arrode, G., Boccaccio, C., Lule, J., Allart, S., Moinard, N., Abastado, J. P., Alam, A. and Davrinche, C., Incoming human cytomegalovirus pp65 (UL83) contained in apoptotic infected fibroblasts is cross-presented to CD8(+) T cells by dendritic cells. J. Virol. 2000. 74: 10018-10024.
84. Belz, G. T., Smith, C. M., Eichner, D., Shortman, K., Karupiah, G., Carbone, F. R. and Heath, W. R., Cutting edge: Conventional CD8 alpha+ dendritic cells are generally involved in priming CTL immunity to viruses. J. Immunol. 2004. 172: 1996-2000.
85. Nikkels, A. F., Debrus, S., Sadzot-Delvaux, C., Piette, J., Rentier, B. and Pierard, G. E., Localization of varicella-zoster virus nucleic acids and proteins in human skin. Neurology 1995. 45: S47-S49.
86. Nikkels, A. F., Sadzot-Delvaux, C. and Pierard, G. E., Absence of intercellular adhesion molecule 1 expression in varicella zoster virus-infected keratinocytes during herpes zoster: Another immune evasion strategy? Am. J. Dermatopathol. 2004. 26: 27-32.
87. Morrow, G., Slobedman, B., Cunningham, A. L. and Abendroth, A., Varicella-zoster virus productively infects mature dendritic cells and alters their immune function. J. Virol. 2003. 77: 4950-4959.
88. Bosnjak, L., Jones, C. A., Abendroth, A. and Cunningham, A. L., Dendritic cell biology in herpesvirus infections. Viral. Immunol. 2005. 18: 419-433.